| Biological Information | |
|---|---|
| Background Information: | Bromosporine is a synthetic small molecule pan-bromodomain inhibitor developed by the Structural Genomics Consortium for research. It is shown to accelerate FRAP recovery of BRD4 and CREBBP in cells at 1uM concentration. Bromodomains are implicated in multiple cellular processes, including inflammatory gene expression, mitosis, and viral/host interaction. Provided as 10 mg of dry powder. |
| Target Name: | Bromosporine |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at 2-8°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Bromosporine
Bromosporine is an inhibitor for bromodomain-containing proteins including BRD9. This product is provided as 10 mg of dry powder.
Datasheets
92-1239 Datasheet
View Document